Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results - Martin, D F; Maguire, M G; Fine, S L; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group (Ophthalmology, 2012)